Description
Long-acting insulin-like growth factor-1 analog
IGF-1 LR3 is an extended-activity version of Insulin-like Growth Factor-1, designed to promote cellular growth, boost protein synthesis, and support fat loss. With a significantly longer half-life than standard IGF-1, delivers sustained anabolic effects. Improves nutrient partitioning by directing nutrients into muscle tissue rather than fat storage. Also plays a vital role in tissue repair and recovery, aiding in faster healing from physical stress and injuries.
- Lu Z, et al. Recombinant expression of IGF-1 and LR3 IGF-1 fused with xylanase in Pichia pastoris. Appl Microbiol Biotechnol. 2023;107(14):4543-4551. PMID: 37261455 | DOI: 10.1007/s00253-023-12606-0
- Thomas FH, et al. Effects of IGF-I bioavailability on bovine preantral follicular development in vitro. Reproduction. 2007;133(6):1121-1128. PMID: 17636166 | DOI: 10.1530/REP-06-0382
- Levolger S, et al. Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting. Sci Rep. 2019;9(1):9826. PMID: 31285507 | DOI: 10.1038/s41598-019-46178-9
Note: Exact-name literature is thin; the papers above explicitly employ the Long R3 IGF-1 analog.
